Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 13/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5365886 | 0.93 | FKBP1A (0.52) | FKBP1ANPC1 | |
| SCHEMBL14423330 | 0.92 | FKBP1A (0.51) | FKBP1A | |
| SCHEMBL5365865 | 0.91 | FKBP1A (0.50) | FKBP1A | |
| SCHEMBL5372783 | 0.89 | FKBP1A (0.53) | FKBP1ANPC1 | |
| SCHEMBL5364078 | 0.88 | FKBP1A (0.52) | FKBP1A | |
| SCHEMBL5373037 | 0.82 | FKBP1A (0.53) | FKBP1A | |
| SCHEMBL5364042 | 0.80 | FKBP1A (0.62) | FKBP1A | |
| SCHEMBL5375908 | 0.79 | FKBP1A (0.58) | FKBP1A | |
| SCHEMBL5364249 | 0.79 | FKBP1A (0.55) | FKBP1A | |
| SCHEMBL5368168 | 0.78 | FKBP1A (0.64) | FKBP1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020028814-A1 | Aza compounds, pharmaceutical compositions and methods of use | GLIAMED, INC. | 2002-03-07 | — | — | US | claimed |
| US-7253169-B2 | Aza compounds, pharmaceutical compositions and methods of use | GLIAMED, INC. (US) | 2007-08-07 | — | — | US | disclosed |
| US-7253169-B2 | Aza compounds, pharmaceutical compositions and methods of use | GLIAMED, INC. (US) | 2007-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028814-A1 | Aza compounds, pharmaceutical compositions and methods of use | GRIN3A, CHRNA5, GRIN3B | FKBP1A 1238/4885NPC1 757/4885TDP1 1046/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.